MURR ships radioisotope for cancer treatment

The University of Missouri Research Reactor (MURR) is the only U.S. supplier of the radioisotope, produced using a propriety process developed at MURR.

Dec. 6, 2023

MURR recently completed its first commercial shipment of no-carrier-added lutetium-177 for human use and is providing weekly deliveries to Novartis for use in cancer treatments.